News articles for Galderma Laboratories, L.P.:
Thursday, December 15, 2011
Friday, November 19, 2010
Galderma Announces Results of Largest-Ever Rosacea Trial
FORT WORTH, TX -- (Marketwire) -- 11/19/10 -- Results from ORCA (Oracea® for Rosacea: A Community-Based Assessment), a community-based study of 1,421 patients with mild to severe papulopustular rosacea (PPR), found that in patients suffering from PPR, Oracea® (doxycycline 40 mg) effectively reduces rosacea pustules and papules when used ...
read more